BOSCOLO BIELO, LUCA
 Distribuzione geografica
Continente #
EU - Europa 403
AS - Asia 98
NA - Nord America 65
SA - Sud America 5
AF - Africa 1
OC - Oceania 1
Totale 573
Nazione #
DE - Germania 268
IT - Italia 73
US - Stati Uniti d'America 61
SG - Singapore 35
CN - Cina 31
SE - Svezia 17
HK - Hong Kong 13
RU - Federazione Russa 12
FR - Francia 8
FI - Finlandia 7
NL - Olanda 6
IN - India 5
BR - Brasile 4
ID - Indonesia 4
AT - Austria 3
JP - Giappone 3
ES - Italia 2
IE - Irlanda 2
PA - Panama 2
PH - Filippine 2
AU - Australia 1
BE - Belgio 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GB - Regno Unito 1
IQ - Iraq 1
KR - Corea 1
MX - Messico 1
MY - Malesia 1
TR - Turchia 1
UA - Ucraina 1
VN - Vietnam 1
Totale 573
Città #
Frankfurt am Main 262
Milan 34
Singapore 15
Santa Clara 12
Oklahoma City 7
Shanghai 7
Boston 6
Rome 6
Council Bluffs 5
Rho 5
Hong Kong 4
Hyderabad 4
Jakarta 4
Lappeenranta 4
Paris 4
Amsterdam 3
Brescia 3
Helsinki 3
Naples 3
Vienna 3
Alcamo 2
Ashburn 2
Barcelona 2
Beijing 2
Berlin 2
Bron 2
Caivano 2
Dublin 2
Fuzhou 2
Los Angeles 2
Lumezzane 2
Manila 2
Marseille 2
New York 2
Nuremberg 2
Padova 2
Quanzhou 2
Tokyo 2
Trieste 2
Umeå 2
Verona 2
Bengaluru 1
Boardman 1
Brussels 1
Cairo 1
Campina Grande 1
Caserta 1
Culiacán 1
Ercolano 1
Forest City 1
Gainesville 1
Incheon 1
La Paz 1
London 1
Melbourne 1
Meta 1
Moscow 1
Mosul 1
Munich 1
Newark 1
Oakland 1
Osasco 1
Prague 1
San Antonio 1
San Diego 1
São José dos Campos 1
São Paulo 1
Tallinn 1
Wuhan 1
Yubileyny 1
Çanakkale 1
Totale 466
Nome #
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents 126
Future potential targets of antibody-drug conjugates in breast cancer 113
Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer 103
Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents 82
Radiation therapy, tissue radiosensitization, and potential synergism in the era of novel antibody-drug conjugates 66
Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatments 58
The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I Unit 15
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact 13
Germline BRCA pathogenic variants in patients with ovarian cancer and post-poly (ADP-ribose) polymerase inhibitor myeloid neoplasms 11
Genomic and clinical landscape of metastatic hormone receptors-positive breast cancers carrying ESR1 alterations 9
Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience 8
Germline BRCA pathogenic variants and hematologic adverse events in patients with ovarian carcinoma receiving PARP inhibitors: a retrospective cohort study 5
Variant allele frequency: a decision-making tool in precision oncology? 1
The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer 1
Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study 1
Molecular tumor board in patients with metastatic breast cancer 1
Totale 613
Categoria #
all - tutte 1.725
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.725


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024298 5 5 13 11 18 20 35 23 23 34 54 57
2024/2025315 49 44 50 39 18 10 9 62 34 0 0 0
Totale 613